> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Addressing Product Misinformation
- URL: https://www.fdaweb.com/draft-guide-on-addressing-product-misinformation/
- Published: 2024-07-09T12:00:00.000Z
- Updated: 2026-09-14T14:34:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157306

*Federal Register* notice: FDA makes available a revised draft guidance entitled “Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers.” The document describes FDA’s current thinking on common questions firms may have when voluntarily addressing misinformation about their approved/cleared medical products. It revises and replaces a 6/2014 draft guidance entitled “Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices.” To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-07-09/pdf/2024-15009.pdf?ref=fdaweb.com).